{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:51:22Z","timestamp":1791917482477,"version":"4.3.4"},"reference-count":138,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK132781"],"award-info":[{"award-number":["R01DK132781"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001172","name":"Hormel Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ajpath.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T12:13:14Z","timestamp":1688645594000},"page":"1455-1467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-6616","authenticated-orcid":false,"given":"Kishor","family":"Pant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3222-428X","authenticated-orcid":false,"given":"Senthil K.","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6639-2965","authenticated-orcid":false,"given":"Maria J.","family":"Lorenzo Pisarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-3634","authenticated-orcid":false,"given":"Sergio A.","family":"Gradilone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2023.06.007_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib2","doi-asserted-by":"crossref","first-page":"14185","DOI":"10.3748\/wjg.v20.i39.14185","article-title":"Nonalcoholic fatty liver disease and aging: epidemiology to management","volume":"20","author":"Bertolotti","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.2002.tb11467.x","article-title":"The microbiology of butyrate formation in the human colon","volume":"217","author":"Pryde","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ajpath.2023.06.007_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-4827(92)90144-W","article-title":"Transforming growth factor-beta 1 acts cooperatively with sodium n-butyrate to induce differentiation of normal human keratinocytes","volume":"198","author":"Wang","year":"1992","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ajpath.2023.06.007_bib6","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1128\/AEM.00589-13","article-title":"Butyrate-producing bacteria, including mucin degraders, from the swine intestinal tract","volume":"79","author":"Levine","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2009.01514.x","article-title":"Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine","volume":"294","author":"Louis","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ajpath.2023.06.007_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1017\/S0954422410000247","article-title":"From the gut to the peripheral tissues: the multiple effects of butyrate","volume":"23","author":"Guilloteau","year":"2010","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.ajpath.2023.06.007_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/mic.0.28412-0","article-title":"A novel class of CoA-transferase involved in short-chain fatty acid metabolism in butyrate-producing human colonic bacteria","volume":"152","author":"Charrier","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6793-8-19","article-title":"Butyrate ingestion improves hepatic glycogen storage in the re-fed rat","volume":"8","author":"Beauvieux","year":"2008","journal-title":"BMC Physiol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nutres.2022.07.007","article-title":"Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders","volume":"106","author":"Yadav","year":"2022","journal-title":"Nutr Res"},{"key":"10.1016\/j.ajpath.2023.06.007_bib13","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1080\/10408398.2021.1895064","article-title":"Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): an updated review","volume":"62","author":"Rauf","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.ajpath.2023.06.007_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.32449","article-title":"Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC","volume":"77","author":"Hu","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib15","doi-asserted-by":"crossref","first-page":"G900","DOI":"10.1152\/ajpgi.00265.2013","article-title":"Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids","volume":"305","author":"den Besten","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2023.06.007_bib17","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/jgh.15899","article-title":"The effect of increasing intestinal short-chain fatty acid concentration on gut permeability and liver injury in the context of liver disease: a systematic review","volume":"37","author":"Pohl","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72171","article-title":"Short-chain fatty acids activate acetyltransferase p300","volume":"10","author":"Thomas","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ajpath.2023.06.007_bib19","first-page":"5244","article-title":"Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells","volume":"96","author":"Silva","year":"2018","journal-title":"J Anim Sci"},{"key":"10.1016\/j.ajpath.2023.06.007_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245348","article-title":"Colon cancer cell differentiation by sodium butyrate modulates metabolic plasticity of Caco-2 cells via alteration of phosphotransfer network","volume":"16","author":"Klepinina","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2023.06.007_bib21","doi-asserted-by":"crossref","first-page":"e00905","DOI":"10.1128\/IAI.00905-16","article-title":"MUC2 mucin and butyrate contribute to the synthesis of the antimicrobial peptide cathelicidin in response to entamoeba histolytica- and dextran sodium sulfate-induced colitis","volume":"85","author":"Cobo","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.ajpath.2023.06.007_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1938380","article-title":"Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor","volume":"13","author":"Wang","year":"2021","journal-title":"Gut Microb"},{"key":"10.1016\/j.ajpath.2023.06.007_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-009-1573-7","article-title":"The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation","volume":"53","author":"Kolb","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajpath.2023.06.007_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib25","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1038\/cti.2016.17","article-title":"Regulation of immune cell function by short-chain fatty acids","volume":"5","author":"Corr\u00eaa-Oliveira","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib26","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0024-3205(03)00490-9","article-title":"Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes","volume":"73","author":"Cavaglieri","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.ajpath.2023.06.007_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2007.06.023","article-title":"Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen","volume":"571","author":"Arai","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib28","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1084\/jem.144.6.1674","article-title":"Effect of sodium butyrate on lymphocyte activation","volume":"144","author":"Kyner","year":"1976","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2023.06.007_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2567.2002.01457.x","article-title":"The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors","volume":"106","author":"Jackson","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1023\/A:1014781109498","article-title":"Butyrate strongly inhibits in\u00a0vitro stimulated release of cytokines in blood","volume":"47","author":"Nancey","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajpath.2023.06.007_bib31","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.3748\/wjg.v19.i42.7327","article-title":"Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver","volume":"19","author":"Rojas-Feria","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/642923","article-title":"Liver disorders in inflammatory bowel disease","volume":"2012","author":"Uko","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ajpath.2023.06.007_bib33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.imbio.2010.01.001","article-title":"Butyrate in\u00a0vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis","volume":"215","author":"Bail\u00f3n","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib34","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3390\/cancers12113336","article-title":"The role of oxidative stress and its counteractive utility in colorectal cancer (CRC)","volume":"12","author":"Basak","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2023.06.007_bib35","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/carcin\/22.10.1675","article-title":"Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells","volume":"22","author":"Rosignoli","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2023.06.007_bib36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jnutbio.2006.12.012","article-title":"Physiological concentrations of butyrate favorably modulate genes of oxidative and metabolic stress in primary human colon cells","volume":"18","author":"Sauer","year":"2007","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.ajpath.2023.06.007_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clnu.2008.11.002","article-title":"Butyrate modulates oxidative stress in the colonic mucosa of healthy humans","volume":"28","author":"Hamer","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ajpath.2023.06.007_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068626","article-title":"Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet","volume":"8","author":"Mattace Raso","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2023.06.007_bib39","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1053\/j.gastro.2007.08.041","article-title":"Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation","volume":"133","author":"Thibault","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib40","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2023.06.007_bib41","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/ajcn\/nqac246","article-title":"A randomized dietary intervention to increase colonic and peripheral blood SCFAs modulates the blood B- and T-cell compartments in healthy humans","volume":"116","author":"Gill","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajpath.2023.06.007_bib42","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1096\/fj.00-0359fje","article-title":"Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production","volume":"14","author":"S\u00e4emann","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2023.06.007_bib43","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41598-018-37246-7","article-title":"Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males","volume":"9","author":"Cleophas","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2023.06.007_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1067647","article-title":"Protective role of butyrate in obesity and diabetes: new insights","volume":"9","author":"Mayorga-Ramos","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.ajpath.2023.06.007_bib45","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ibd.21108","article-title":"Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency","volume":"16","author":"Thibault","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajpath.2023.06.007_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5551\/jat.15065","article-title":"Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages","volume":"20","author":"Ohira","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ajpath.2023.06.007_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.47.3.397","article-title":"Butyrate inhibits inflammatory responses through NF\u03baB inhibition: implications for Crohn's disease","volume":"47","author":"Segain","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2023.06.007_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2005.07.003","article-title":"Repression of interferon-\u03b3-induced inducible nitric oxide synthase (iNOS) gene expression in microglia by sodium butyrate is mediated through specific inhibition of ERK signaling pathways","volume":"168","author":"Park","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2004.02.006","article-title":"Sodium butyrate suppresses interferon-gamma-, but not lipopolysaccharide-mediated induction of nitric oxide and tumor necrosis factor-alpha in microglia","volume":"151","author":"Kim","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib50","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.3748\/wjg.v26.i40.6224","article-title":"New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism","volume":"26","author":"Jiang","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/nu11010097","article-title":"A designer synbiotic attenuates chronic-binge ethanol-induced gut-liver injury in mice","volume":"11","author":"Roychowdhury","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpath.2023.06.007_bib52","first-page":"583","article-title":"Nonalcoholic fatty liver disease","volume":"99","author":"Hjelkrem","year":"2008","journal-title":"Minerva Med"},{"key":"10.1016\/j.ajpath.2023.06.007_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080476","article-title":"High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects","volume":"8","author":"Jakobsdottir","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2023.06.007_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063388","article-title":"Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis","volume":"8","author":"Endo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2023.06.007_bib55","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2014.07.044","article-title":"Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets","volume":"147","author":"Fisher","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib56","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.metabol.2014.11.009","article-title":"The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy","volume":"64","author":"Liu","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpath.2023.06.007_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067160","article-title":"Association\u00a0between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease","volume":"8","author":"Alisi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2023.06.007_bib58","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/db11-0846","article-title":"Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3","volume":"61","author":"Li","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpath.2023.06.007_bib59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Abu-Shanab","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib60","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2023.06.007_bib61","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.2527\/2004.82123549x","article-title":"Effect of increasing ruminal butyrate absorption on splanchnic metabolism of volatile fatty acids absorbed from the washed reticulorumen of steers","volume":"82","author":"Kristensen","year":"2004","journal-title":"J Anim Sci"},{"key":"10.1016\/j.ajpath.2023.06.007_bib62","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1111\/bph.13058","article-title":"Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning","volume":"172","author":"Henagan","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib63","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpath.2023.06.007_bib64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0028-1091985","article-title":"Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery","volume":"28","author":"Verna","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ajpath.2023.06.007_bib65","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","article-title":"From the metabolic syndrome to NAFLD or vice versa?","volume":"42","author":"Vanni","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajpath.2023.06.007_bib66","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1007\/s10620-013-2744-4","article-title":"Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity","volume":"58","author":"Soldavini","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajpath.2023.06.007_bib67","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1079\/BJN20061713","article-title":"Hydrothermal treatment of Novelose 330 results in high yield of resistant starch type 3 with beneficial prebiotic properties and decreased secondary bile acid formation in rats","volume":"95","author":"Jacobasch","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ajpath.2023.06.007_bib68","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nbt.2845","article-title":"You are what you eat","volume":"32","author":"Br\u00fcssow","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib69","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jcmgh.2021.05.006","article-title":"Sodium butyrate supplementation inhibits hepatic steatosis by stimulating liver kinase B1 and insulin-induced gene","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib70","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1017\/S0007114515003621","article-title":"Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)","volume":"114","author":"Jin","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ajpath.2023.06.007_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0183-1","article-title":"Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression","volume":"50","author":"Zhou","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ajpath.2023.06.007_bib72","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3390\/biomedicines9121954","article-title":"Butyrate protects against diet-induced NASH and liver fibrosis and suppresses specific non-canonical TGF-\u03b2 signaling pathways in human hepatic stellate cells","volume":"9","author":"Gart","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpath.2023.06.007_bib73","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1745-7254.2005.00195.x","article-title":"Histone deacetylase inhibitors for treatment of hepatocellular carcinoma","volume":"26","author":"Coradini","year":"2005","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ajpath.2023.06.007_bib74","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1111\/jcmm.17322","article-title":"Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc\/hexokinase 2 pathway","volume":"26","author":"Yu","year":"2022","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ajpath.2023.06.007_bib75","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1007\/s11033-011-1443-5","article-title":"Dual effects of sodium butyrate on hepatocellular carcinoma cells","volume":"39","author":"Jiang","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ajpath.2023.06.007_bib76","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","article-title":"Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells","volume":"12","author":"Pant","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib77","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mc.22946","article-title":"Butyrate inhibits HBV replication and HBV-induced hepatoma cell proliferation via modulating SIRT-1\/Ac-p53 regulatory axis","volume":"58","author":"Pant","year":"2019","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.ajpath.2023.06.007_bib78","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ejca.2004.01.039","article-title":"Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria\/caspase pathway, associated with degradation of \u03b2-catenin, pRb and Bcl-XL","volume":"40","author":"Emanuele","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2023.06.007_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2017.06.001","article-title":"Oxidative stress plays a key role in butyrate-mediated autophagy via Akt\/mTOR pathway in hepatoma cells","volume":"273","author":"Pant","year":"2017","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ajpath.2023.06.007_bib80","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2003.09.021","article-title":"Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells","volume":"40","author":"Ogawa","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib81","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/ijc.24212","article-title":"Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug","volume":"124","author":"Kuroiwa-Trzmielina","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2023.06.007_bib82","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/carcin\/bgt124","article-title":"The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway","volume":"34","author":"Conti","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2023.06.007_bib83","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jnutbio.2011.04.010","article-title":"Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis","volume":"23","author":"de Conti","year":"2012","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.ajpath.2023.06.007_bib84","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/mnfr.201500643","article-title":"The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis","volume":"60","author":"Heidor","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.ajpath.2023.06.007_bib85","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.taap.2014.02.004","article-title":"The chemopreventive activity of the histone deacetylase inhibitor tributyrin in colon carcinogenesis involves the induction of apoptosis and reduction of DNA damage","volume":"276","author":"Heidor","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib86","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","article-title":"The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2023.06.007_bib87","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2023.06.007_bib88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fmed.2020.00113","article-title":"Role of glucose metabolism reprogramming in the pathogenesis of cholangiocarcinoma","volume":"7","author":"Pant","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.ajpath.2023.06.007_bib89","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","article-title":"The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation","volume":"48","author":"Donohoe","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2023.06.007_bib90","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1158\/2159-8290.CD-14-0501","article-title":"A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner","volume":"4","author":"Donohoe","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2023.06.007_bib91","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00441-002-0593-0","article-title":"Massive apoptosis of colonocytes induced by butyrate deprivation overloads resident macrophages and promotes the recruitment of circulating monocytes","volume":"309","author":"Luciano","year":"2002","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ajpath.2023.06.007_bib92","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jn\/135.2.291","article-title":"Prolonged butyrate treatment inhibits the migration and invasion potential of HT1080 tumor cells","volume":"135","author":"Zeng","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.ajpath.2023.06.007_bib93","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3109\/10428194.2012.663085","article-title":"Hyper-activation of WNT\/\u03b2-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia","volume":"53","author":"Shao","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ajpath.2023.06.007_bib94","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cbi.2010.03.035","article-title":"Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells","volume":"185","author":"Zhang","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ajpath.2023.06.007_bib95","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3892\/ijmm.2013.1285","article-title":"Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in\u00a0vitro","volume":"31","author":"Wang","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ajpath.2023.06.007_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/096504008784046108","article-title":"Hyperinduction of Wnt activity: a new paradigm for the treatment of colorectal cancer?","volume":"17","author":"Bordonaro","year":"2008","journal-title":"Oncol Res"},{"key":"10.1016\/j.ajpath.2023.06.007_bib97","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jhep.2013.07.001","article-title":"Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs","volume":"59","author":"Pez","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib98","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1290\/1071-2690(2000)036<0387:UROECA>2.0.CO;2","article-title":"Up-regulation of E-cadherin and \u03b2-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-\u03b1","volume":"36","author":"Masuda","year":"2000","journal-title":"In\u00a0Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.ajpath.2023.06.007_bib99","article-title":"Short chain fatty acid, butyrate, induces cilia formation and potentiates the effects of HDAC6 inhibitors in cholangiocarcinoma cells","volume":"13","author":"Pant","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/cells9030780","article-title":"Role of histone deacetylases in carcinogenesis: potential role in cholangiocarcinoma","volume":"9","author":"Pant","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2023.06.007_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113906","article-title":"The primary cilium: its role as a tumor suppressor organelle","volume":"175","author":"Peixoto","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib102","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2174\/1389450116666150223162737","article-title":"Primary cilia in tumor biology: the primary cilium as a therapeutic target in cholangiocarcinoma","volume":"18","author":"Gradilone","year":"2017","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ajpath.2023.06.007_bib103","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/hep.32080","article-title":"Histone deacetylase SIRT1 promotes loss of primary cilia in cholangiocarcinoma","volume":"74","author":"Pant","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib104","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MOT.0b013e32833991e3","article-title":"Current status of donation after cardiac death liver transplantation","volume":"15","author":"Reich","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.ajpath.2023.06.007_bib105","article-title":"Butyrate protects rat liver against total hepatic ischemia reperfusion injury with bowel congestion","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2023.06.007_bib106","doi-asserted-by":"crossref","first-page":"21069","DOI":"10.3390\/ijms151121069","article-title":"Inhibition of histone deacetylase by butyrate protects rat liver from ischemic reperfusion injury","volume":"15","author":"Sun","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2023.06.007_bib107","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jss.2015.04.031","article-title":"Protective effects of butyrate on intestinal ischemia-reperfusion injury in rats","volume":"197","author":"Qiao","year":"2015","journal-title":"J Surg Res"},{"key":"10.1016\/j.ajpath.2023.06.007_bib108","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/carcin\/bgi059","article-title":"Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics","volume":"26","author":"Pool-Zobel","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2023.06.007_bib109","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fmicb.2020.01662","article-title":"Criteria to qualify microorganisms as \u201cprobiotic\u201d in foods and dietary supplements","volume":"11","author":"Binda","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib110","series-title":"Guidelines for the Evaluation of Probiotics in Food","year":"2002"},{"key":"10.1016\/j.ajpath.2023.06.007_bib111","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1907272","article-title":"Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease","volume":"13","author":"Stoeva","year":"2021","journal-title":"Gut Microb"},{"key":"10.1016\/j.ajpath.2023.06.007_bib113","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/MEG.0000000000001371","article-title":"The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis","volume":"31","author":"Khan","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib114","doi-asserted-by":"crossref","first-page":"88894","DOI":"10.18632\/oncotarget.21491","article-title":"Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2023.06.007_bib115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cgh.2018.07.026","article-title":"Fecal microbiota transplantation: current status in treatment of GI and liver disease","volume":"17","author":"Vaughn","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib116","doi-asserted-by":"crossref","first-page":"17127","DOI":"10.1002\/jcp.28473","article-title":"Importance of probiotics in the prevention and treatment of colorectal cancer","volume":"234","author":"Eslami","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib117","article-title":"Cross-talk between butyric acid and gut microbiota in ulcerative colitis following fecal microbiota transplantation","volume":"12","author":"Xu","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib118","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib119","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/hep.29369","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Mullish","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib120","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.3748\/wjg.v23.i38.6983","article-title":"Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction","volume":"23","author":"Wang","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/srep25001","article-title":"Alteration of the serum microbiome composition in cirrhotic patients with ascites","volume":"6","author":"Santiago","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2023.06.007_bib122","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib123","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2023.06.007_bib124","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jhep.2016.11.008","article-title":"Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice","volume":"66","author":"Ferrere","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s002800050922","article-title":"Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats","volume":"43","author":"Egorin","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib126","first-page":"629","article-title":"Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors","volume":"4","author":"Conley","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2023.06.007_bib127","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00280-003-0580-5","article-title":"Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug","volume":"51","author":"Edelman","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib128","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/jgh.13731","article-title":"Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury","volume":"32","author":"Cresci","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib129","doi-asserted-by":"crossref","DOI":"10.1017\/jns.2017.54","article-title":"Effects of monobutyrin and tributyrin on liver lipid profile, caecal microbiota composition and SCFA in high-fat diet-fed rats","volume":"6","author":"Nguyen","year":"2017","journal-title":"J Nutr Sci"},{"key":"10.1016\/j.ajpath.2023.06.007_bib130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clnu.2010.09.012","article-title":"Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats","volume":"30","author":"Miyoshi","year":"2011","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ajpath.2023.06.007_bib131","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.clnesp.2015.02.001","article-title":"Oral tributyrin prevents endotoxin-induced lipid metabolism disorder","volume":"10","author":"Miyoshi","year":"2015","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.ajpath.2023.06.007_bib132","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cmet.2018.10.009","article-title":"When soluble fibers meet hepatocellular carcinoma: the dark side of fermentation","volume":"28","author":"Gallage","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2023.06.007_bib133","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hbpd.2018.11.002","article-title":"Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis","volume":"18","author":"Jiang","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.ajpath.2023.06.007_bib134","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2018.09.004","article-title":"Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer","volume":"175","author":"Singh","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2023.06.007_bib135","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cmet.2015.09.028","article-title":"Microbiota-dependent hepatic lipogenesis mediated by stearoyl CoA desaturase 1 (SCD1) promotes metabolic syndrome in TLR5-deficient mice","volume":"22","author":"Singh","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2023.06.007_bib136","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1136\/gutjnl-2018-316250","article-title":"Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation","volume":"68","author":"Singh","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2023.06.007_bib137","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1099\/jmm.0.017541-0","article-title":"Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease","volume":"59","author":"Van Immerseel","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ajpath.2023.06.007_bib138","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/nu14091977","article-title":"Intestinal microbiota-derived short chain fatty acids in host health and disease","volume":"14","author":"Cong","year":"2022","journal-title":"Nutrients"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944023002389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944023002389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:44:13Z","timestamp":1757695453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944023002389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":138,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0002944023002389"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2023.06.007","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}